
Validea's guru fundamental report assigned ARTHUR J. GALLAGHER & CO. (AJG), a large-cap growth insurance stock, a 56% rating using its Warren Buffett-inspired 'Patient Investor' model. This score, which is below the 80% threshold for 'some interest,' indicates that AJG does not strongly align with the model's criteria for long-term, predictably profitable firms with low debt and reasonable valuations, despite passing tests for earnings predictability, return on assets, free cash flow, and use of retained earnings, while failing on return on equity, initial rate of return, and expected return.
Arthur J. Gallagher & Co. (AJG) garners a mediocre 56% rating from Validea's 'Patient Investor' model, which is based on Warren Buffett's investment principles. This score is notably below the 80% threshold required to signal even moderate interest from the strategy, indicating a mixed fundamental profile. The analysis reveals a clear divergence between the company's operational quality and its investment appeal at the current valuation. On the positive side, AJG passes crucial tests for earnings predictability, return on assets (ROA), free cash flow generation, and the effective use of retained earnings. These factors suggest a stable, well-managed business with consistent profitability. However, these strengths are offset by significant failures in key return-focused metrics, specifically return on equity (ROE), initial rate of return, and expected future return. These failures, reflected in the mildly negative sentiment score, imply that despite its sound operations, the stock is likely priced too high to offer a compelling return for value-oriented investors. The neutral rating on share repurchases does little to alter this overall assessment, which points to a quality company whose valuation may have gotten ahead of its fundamentals.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment